Quest Partners LLC increased its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 299,333.3% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 8,983 shares of the financial services provider's stock after acquiring an additional 8,980 shares during the period. Quest Partners LLC's holdings in MetLife were worth $741,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of MET. Dimensional Fund Advisors LP increased its holdings in MetLife by 22.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider's stock worth $378,799,000 after purchasing an additional 988,666 shares during the last quarter. Legal & General Group Plc increased its holdings in MetLife by 5.4% during the 2nd quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider's stock worth $371,993,000 after purchasing an additional 269,246 shares during the last quarter. Envestnet Asset Management Inc. increased its holdings in MetLife by 3.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 3,224,930 shares of the financial services provider's stock worth $226,358,000 after purchasing an additional 100,782 shares during the last quarter. AustralianSuper Pty Ltd increased its holdings in MetLife by 0.8% during the 2nd quarter. AustralianSuper Pty Ltd now owns 2,063,607 shares of the financial services provider's stock worth $144,845,000 after purchasing an additional 16,985 shares during the last quarter. Finally, Swedbank AB increased its holdings in MetLife by 5.3% during the 3rd quarter. Swedbank AB now owns 1,970,163 shares of the financial services provider's stock worth $162,499,000 after purchasing an additional 99,328 shares during the last quarter. 89.81% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
MET has been the subject of a number of research analyst reports. Barclays lowered their price target on MetLife from $91.00 to $90.00 and set an "overweight" rating for the company in a report on Thursday, October 31st. TD Cowen started coverage on MetLife in a report on Wednesday, October 9th. They issued a "buy" rating and a $97.00 price target for the company. Morgan Stanley reduced their price objective on MetLife from $86.00 to $85.00 and set an "overweight" rating for the company in a research report on Monday, August 19th. StockNews.com upgraded MetLife from a "hold" rating to a "buy" rating in a research report on Tuesday, November 12th. Finally, Piper Sandler boosted their price target on MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 2nd. Fourteen equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $88.46.
View Our Latest Report on MET
MetLife Trading Up 1.7 %
Shares of MetLife stock traded up $1.41 on Friday, reaching $86.60. 3,270,127 shares of the company were exchanged, compared to its average volume of 3,317,860. The stock has a fifty day moving average price of $82.27 and a 200-day moving average price of $75.91. The firm has a market capitalization of $59.96 billion, a price-to-earnings ratio of 17.21, a price-to-earnings-growth ratio of 0.75 and a beta of 1.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a fifty-two week low of $62.81 and a fifty-two week high of $86.94.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date is Tuesday, November 5th. MetLife's dividend payout ratio (DPR) is presently 43.95%.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.